{"id":52286,"date":"2023-09-20T09:31:27","date_gmt":"2023-09-20T09:31:27","guid":{"rendered":"https:\/\/medsname.com\/hepcvir-l\/"},"modified":"2026-05-01T05:18:01","modified_gmt":"2026-05-01T05:18:01","slug":"hepcvir-l","status":"publish","type":"product","link":"https:\/\/medsbase.com\/cs\/product\/hepcvir-l\/","title":{"rendered":"Hepcvir L"},"content":{"rendered":"<div class=\"medsbase-tldr-answer\" style=\"background:#fff8e1;border-left:4px solid #f5a623;padding:14px 18px;margin:18px 0;border-radius:4px;\">\n<h3 style=\"margin-top:0;\">Rychl\u00e1 odpov\u011b\u010f<\/h3>\n<p style=\"margin-bottom:0;\"><strong>Hepcvir L<\/strong> \u2014 sofosbuvir 400 mg + ledipasvir 90 mg fixn\u00ed kombinace (Cipla Inc.). Jednoduch\u00fd re\u017eim v jedn\u00e9 tablet\u011b pro chronickou hepatitidu C genotyp\u016f 1, 4, 5, 6 \u2014 12 t\u00fddn\u016f jednodenn\u00ed peror\u00e1ln\u00ed terapie. \u00dasp\u011b\u0161nost l\u00e9\u010dby \u226595%. Generick\u00fd ekvivalent Gilead Harvoni.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f7f7f7;border-left:4px solid #2c7cb0;padding:14px 18px;margin:18px 0;border-radius:4px;\">\n<p style=\"margin:0 0 6px 0;\"><strong>Co z\u00edsk\u00e1te s MedsBase:<\/strong><\/p>\n<ul style=\"margin:6px 0 0 22px;padding:0;list-style:disc;\">\n<li>v\u00fdrobce certifikovan\u00e9ho WHO-GMP<\/li>\n<li>Diskr\u00e9tn\u00ed balen\u00ed v oby\u010dejn\u00e9 ob\u00e1lce<\/li>\n<li>Dod\u00e1n\u00ed po cel\u00e9m sv\u011bt\u011b<\/li>\n<li>Hodnoceno v\u00edce ne\u017e 1 400 z\u00e1kazn\u00edky (<a href=\"https:\/\/medsbase.com\/cs\/reviews\/\">\u010d\u00edst recenze<\/a>)<\/li>\n<\/ul>\n<\/div>\n<p class=\"medsbase-reship-line\" style=\"background:#eef7ee;border-left:4px solid #4caf50;padding:10px 14px;margin:14px 0;border-radius:3px;\">\ud83d\udce6 <strong>Z\u00e1ruka op\u011btovn\u00e9ho zasl\u00e1n\u00ed:<\/strong> pokud va\u0161e objedn\u00e1vka nedoraz\u00ed do 20 pracovn\u00edch dn\u016f od odesl\u00e1n\u00ed, za\u0161leme ji znovu bez dal\u0161\u00edch n\u00e1klad\u016f. <a href=\"https:\/\/medsbase.com\/cs\/medsbase-re-shipment-assurance-policy\/\">P\u0159e\u010d\u00edst podm\u00ednky<\/a>.<\/p>\n<h3>Pro\u010d objedn\u00e1vat z MedsBase<\/h3>\n<p>Hepcvir L je dod\u00e1v\u00e1n od v\u00fdrobce certifikovan\u00e9ho WHO-GMP v neutr\u00e1ln\u00edm balen\u00ed, fakturov\u00e1n p\u0159es regulovan\u00fd platebn\u00ed procesor (v\u00fdpis na \u00fa\u010dtu ukazuje regulovan\u00e9ho procesora platebn\u00edch karet \u2014 nikdy MedsBase nebo n\u00e1zev l\u00e9ku). Ka\u017ed\u00e1 objedn\u00e1vka zahrnuje na\u0161e 20-pracovn\u00ed-denn\u00ed Reshipment Assurance.<\/p>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:12px 16px;margin:14px 0;border-radius:3px;\"><strong>FDA \u010dern\u00fd r\u00e1me\u010dek: reaktivace HBV<\/strong><br \/>V\u0161echny DAA terapie hepatitidy C nesou varov\u00e1n\u00ed FDA v \u010dern\u00e9m r\u00e1me\u010dku ohledn\u011b reaktivace viru hepatitidy B u pacient\u016f s koinfekc\u00ed HCV + HBV (co\u017e m\u016f\u017ee b\u00fdt fulminantn\u00ed a fat\u00e1ln\u00ed). P\u0159ed zah\u00e1jen\u00edm jak\u00e9hokoli DAA re\u017eimu testujte HBsAg a HBV DNA. Pokud je HBV pozitivn\u00ed, hepatolog mus\u00ed zajistit spole\u010dnou l\u00e9\u010dbu nebo profylaktickou anti-HBV terapii.<\/div>\n<h2>Jak to funguje<\/h2>\n<p>Dv\u011b komplement\u00e1rn\u00ed p\u0159\u00edmo p\u016fsob\u00edc\u00ed antivirotika v jedn\u00e9 tablet\u011b:<\/p>\n<ul>\n<li><strong>Sofosbuvir<\/strong> \u2014 inhibitor nukleotidov\u00e9 polymer\u00e1zy NS5B (termin\u00e1tor \u0159et\u011bzce)<\/li>\n<li><strong>Ledipasvir<\/strong> \u2014 inhibitor NS5A (replikace a tvorba virion\u016f)<\/li>\n<\/ul>\n<p>Kombinovan\u00fd \u00fatok na dva esenci\u00e1ln\u00ed virov\u00e9 proteiny vytv\u00e1\u0159\u00ed vysokou bari\u00e9ru proti rezistenci. Kombinace je \u00fa\u010dinn\u00e1 pro genotypy 1\/4\/5\/6. Pro genotypy 2 a 3 jsou preferov\u00e1ny kombinace sofosbuvir + velpatasvir nebo sofosbuvir + daclatasvir.<\/p>\n<div style=\"background:#fff8e1;border-left:4px solid #f5a623;padding:12px 16px;margin:14px 0;border-radius:3px;\"><strong>U\u017e\u00edvejte s j\u00eddlem; pozor na inhibitory protonov\u00e9 pumpy<\/strong><br \/>Absorpce ledipasviru je z\u00e1visl\u00e1 na pH. U\u017e\u00edvejte s j\u00eddlem pro maximalizaci hladin. PPI (omeprazol, pantoprazol) sni\u017euj\u00ed absorpci ledipasviru \u2014 u\u017e\u00edvejte DAA tabletu prvn\u00ed r\u00e1no p\u0159ed jakoukoli d\u00e1vkou PPI, NEBO p\u0159ejd\u011bte na H2 blok\u00e1tory (famotidin) nebo antacida b\u011bhem terapie. Antacida by m\u011bla b\u00fdt u\u017e\u00edv\u00e1na s odstupem \u22654 hodin.<\/div>\n<h2>Tabulka d\u00e9lky l\u00e9\u010dby<\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:12px 0;\">\n<tr style=\"background:#2c7cb0;color:#fff;\">\n<th style=\"padding:8px;border:1px solid #ddd;\">Populace<\/th>\n<th style=\"padding:8px;border:1px solid #ddd;\">Re\u017eim<\/th>\n<\/tr>\n<tr>\n<td style=\"padding:8px;border:1px solid #ddd;\">Genotyp 1, 4, 5, 6, l\u00e9\u010debn\u011b naivn\u00ed, bez cirh\u00f3zy<\/td>\n<td style=\"padding:8px;border:1px solid #ddd;\">12 t\u00fddn\u016f jedna tableta denn\u011b<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:8px;border:1px solid #ddd;\">L\u00e9\u010dba u pacient\u016f bez p\u0159edchoz\u00ed l\u00e9\u010dby s kompenzovanou cirh\u00f3zou<\/td>\n<td style=\"padding:8px;border:1px solid #ddd;\">12 t\u00fddn\u016f (24 t\u00fddn\u016f u obt\u00ed\u017en\u011b l\u00e9\u010diteln\u00fdch profil\u016f)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:8px;border:1px solid #ddd;\">L\u00e9\u010dba u pacient\u016f s p\u0159edchoz\u00ed l\u00e9\u010dbou, bez cirh\u00f3zy<\/td>\n<td style=\"padding:8px;border:1px solid #ddd;\">12 t\u00fddnech<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:8px;border:1px solid #ddd;\">L\u00e9\u010debn\u011b zku\u0161en\u00ed s cirh\u00f3zou<\/td>\n<td style=\"padding:8px;border:1px solid #ddd;\">12 t\u00fddn\u016f + ribavirin NEBO 24 t\u00fddn\u016f bez<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:8px;border:1px solid #ddd;\">Dekompenzovan\u00e1 cirh\u00f3za (Child-Pugh B\/C)<\/td>\n<td style=\"padding:8px;border:1px solid #ddd;\">12 t\u00fddn\u016f + ribavirin (pod odborn\u00fdm hepatologick\u00fdm dohledem)<\/td>\n<\/tr>\n<\/table>\n<p>Setrval\u00e1 virologick\u00e1 odpov\u011b\u010f 12 t\u00fddn\u016f po ukon\u010den\u00ed l\u00e9\u010dby (SVR12) je ukazatelem vyl\u00e9\u010den\u00ed \u2014 dosahuje se u ~95-99 % pacient\u016f u modern\u00edch re\u017eim\u016f DAA.<\/p>\n<h2>V\u00fdznamn\u00e9 l\u00e9kov\u00e9 interakce<\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:12px 0;\">\n<tr style=\"background:#2c7cb0;color:#fff;\">\n<th style=\"padding:8px;border:1px solid #ddd;\">L\u00e9k<\/th>\n<th style=\"padding:8px;border:1px solid #ddd;\">\u00da\u010dinek a p\u016fsoben\u00ed<\/th>\n<\/tr>\n<tr>\n<td style=\"padding:8px;border:1px solid #ddd;\">Amiodaron + sofosbuvir<\/td>\n<td style=\"padding:8px;border:1px solid #ddd;\"><strong>Varov\u00e1n\u00ed FDA \u2014 hl\u00e1\u0161eny symptomatick\u00e9 bradykardie a \u00famrt\u00ed.<\/strong> Kombinaci se vyhn\u011bte. Pokud je to nevyhnuteln\u00e9, je nutn\u00fd nemocni\u010dn\u00ed kardiologick\u00fd monitoring.<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:8px;border:1px solid #ddd;\">PPI (omeprazol, pantoprazol)<\/td>\n<td style=\"padding:8px;border:1px solid #ddd;\">Sni\u017euj\u00ed absorpci ledipasviru (z\u00e1visl\u00e9 na pH). Re\u017eimy obsahuj\u00edc\u00ed ledipasvir u\u017e\u00edvejte s j\u00eddlem a PPI v odstupu \u22654 hodin, nebo m\u00edsto nich pou\u017eijte H2 blok\u00e1tory\/antacida. Velpatasvir je tak\u00e9 citliv\u00fd na pH \u2014 stejn\u00e9 doporu\u010den\u00ed.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:8px;border:1px solid #ddd;\">Rifampicin, rifabutin<\/td>\n<td style=\"padding:8px;border:1px solid #ddd;\">Siln\u00e9 induktory CYP3A4 + P-gp \u2014 v\u00fdrazn\u011b sni\u017euj\u00ed hladiny DAA. Kombinaci se vyhn\u011bte.<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:8px;border:1px solid #ddd;\">T\u0159ezalka te\u010dkovan\u00e1<\/td>\n<td style=\"padding:8px;border:1px solid #ddd;\">Indukce CYP3A4 \u2014 sni\u017euje hladiny DAA a zvy\u0161uje riziko selh\u00e1n\u00ed l\u00e9\u010dby. Vyhn\u011bte se po celou dobu terapie.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:8px;border:1px solid #ddd;\">Fenytoin, karbamazepin, oxkarbazepin<\/td>\n<td style=\"padding:8px;border:1px solid #ddd;\">Antikonvulziva s induk\u010dn\u00edm \u00fa\u010dinkem \u2014 v\u00fdrazn\u011b sni\u017euj\u00ed hladiny DAA. P\u0159ed zah\u00e1jen\u00edm l\u00e9\u010dby hepatitidy C p\u0159ejd\u011bte na neindukuj\u00edc\u00ed antiepileptikum (lamotrigin, levetiracetam).<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:8px;border:1px solid #ddd;\">Statiny (rosuvastatin, atorvastatin)<\/td>\n<td style=\"padding:8px;border:1px solid #ddd;\">Variabiln\u00ed zv\u00fd\u0161en\u00ed hladin statin\u016f. Pou\u017e\u00edvejte nejni\u017e\u0161\u00ed d\u00e1vku; rosuvastatin se obecn\u011b vyh\u00fdb\u00e1 p\u0159i kombinaci se sof+vel; atorvastatin je p\u0159ijateln\u00fd v n\u00edzk\u00e9 d\u00e1vce.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:8px;border:1px solid #ddd;\">Warfarin<\/td>\n<td style=\"padding:8px;border:1px solid #ddd;\">INR m\u016f\u017ee kol\u00edsat p\u0159i regeneraci jater b\u011bhem l\u00e9\u010dby DAA. Monitorujte INR t\u00fddn\u011b do stabilizace.<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:8px;border:1px solid #ddd;\">HIV antiretrovirotika<\/td>\n<td style=\"padding:8px;border:1px solid #ddd;\">Tenofovir + ledipasvir \u2014 zv\u00fd\u0161en\u00e1 expozice tenofoviru; monitorujte ren\u00e1ln\u00ed funkci. Efavirenz sni\u017euje hladiny velpatasviru \u2014 vyhn\u011bte se kombinaci. HCV-HIV koinfekce v\u017edy vy\u017eaduje konzultaci specialisty na infek\u010dn\u00ed onemocn\u011bn\u00ed\/hepatologii.<\/td>\n<\/tr>\n<\/table>\n<h2 id=\"faqs\">\u010casto kladen\u00e9 dotazy<\/h2>\n<h3>Jak\u00e1 je m\u00edra vyl\u00e9\u010den\u00ed?<\/h3>\n<p>Modern\u00ed re\u017eimy DAA dosahuj\u00ed setrval\u00e9 virologick\u00e9 odpov\u011bdi (SVR12) \u2014 nedetekovateln\u00e1 HCV RNA 12 t\u00fddn\u016f po l\u00e9\u010db\u011b, pova\u017eov\u00e1no za vyl\u00e9\u010den\u00ed \u2014 u 95-99 % pacient\u016f nap\u0159\u00ed\u010d genotypy. Cirh\u00f3za, p\u0159edchoz\u00ed selh\u00e1n\u00ed l\u00e9\u010dby a HCV\/HIV koinfekce m\u00edrn\u011b sni\u017euj\u00ed m\u00edru odpov\u011bdi.<\/p>\n<h3>Co je SVR12?<\/h3>\n<p>Setrval\u00e1 virologick\u00e1 odpov\u011b\u010f 12 t\u00fddn\u016f po l\u00e9\u010db\u011b. Po dokon\u010den\u00ed 12t\u00fddenn\u00edho cyklu DAA se HCV RNA kontroluje 12 t\u00fddn\u016f po posledn\u00ed d\u00e1vce. Nedetekovateln\u00e1 = vyl\u00e9\u010den\u00ed. Pozdn\u00ed relaps po SVR12 je &lt;1 %.<\/p>\n<h3>Budu pot\u0159ebovat kontroln\u00ed test?<\/h3>\n<p>Ano. HCV RNA na konci l\u00e9\u010dby + 12 t\u00fddn\u016f po l\u00e9\u010db\u011b potvrd\u00ed SVR12. Biochemie jater a FibroScan\/zobrazovac\u00ed metody za 6-12 m\u011bs\u00edc\u016f u pacient\u016f s cirh\u00f3zou k posouzen\u00ed regrese. I po vyl\u00e9\u010den\u00ed screening na hepatocelul\u00e1rn\u00ed karcinom ka\u017ed\u00fdch 6 m\u011bs\u00edc\u016f, pokud je p\u0159\u00edtomna cirh\u00f3za.<\/p>\n<h3>A co hepatitida B?<\/h3>\n<p>V\u0161echny DAA nesou \u010dernou v\u00fdstrahu FDA kv\u016fli reaktivaci HBV u pacient\u016f s koinfekc\u00ed HCV+HBV. P\u0159ed zah\u00e1jen\u00edm l\u00e9\u010dby je nutn\u00e9 testovat HBsAg a HBV DNA. Pokud je HBV pozitivn\u00ed, mus\u00ed b\u00fdt l\u00e9\u010dba koordinov\u00e1na s hepatologem.<\/p>\n<h3>M\u016f\u017eu p\u00edt alkohol?<\/h3>\n<p>B\u011bhem l\u00e9\u010dby a ide\u00e1ln\u011b 6\u201312 m\u011bs\u00edc\u016f po n\u00ed se vyh\u00fdbejte alkoholu. Aktivn\u00ed u\u017e\u00edv\u00e1n\u00ed alkoholu nen\u00ed kontraindikac\u00ed pro l\u00e9\u010dbu DAA, ale zhor\u0161uje dlouhodob\u00e9 v\u00fdsledky po\u0161kozen\u00ed jater bez ohledu na stav HCV.<\/p>\n<h3>T\u011bhotenstv\u00ed?<\/h3>\n<p>Sofosbuvir je FDA kategorie B pro t\u011bhotenstv\u00ed (nejsou dostupn\u00e1 data o teratogenit\u011b u lid\u00ed; data u zv\u00ed\u0159at jsou uklid\u0148uj\u00edc\u00ed). V\u011bt\u0161ina DAA nem\u00e1 dostate\u010dn\u00e1 data o t\u011bhotenstv\u00ed. B\u011bhem l\u00e9\u010dby je standardem antikoncepce. Ribavirin (pou\u017e\u00edvan\u00fd jako dopln\u011bk) je siln\u011b teratogenn\u00ed \u2014 oba partne\u0159i mus\u00ed pou\u017e\u00edvat antikoncepci b\u011bhem l\u00e9\u010dby ribavirinem a 6 m\u011bs\u00edc\u016f po n\u00ed.<\/p>\n<h3>Vedlej\u0161\u00ed \u00fa\u010dinky?<\/h3>\n<p>Modern\u00ed DAA jsou obecn\u011b dob\u0159e sn\u00e1\u0161eny. \u010cast\u00e9: \u00fanava, bolesti hlavy, nevolnost, nespavost. M\u00e9n\u011b \u010dast\u00e9: vyr\u00e1\u017eka, pr\u016fjem. Vedlej\u0161\u00ed \u00fa\u010dinky vedouc\u00ed k ukon\u010den\u00ed l\u00e9\u010dby jsou vz\u00e1cn\u00e9.<\/p>\n<h3>Generick\u00fd vs. origin\u00e1ln\u00ed \u2014 z\u00e1le\u017e\u00ed na tom?<\/h3>\n<p>Indick\u00e9 generick\u00e9 DAA jsou vyr\u00e1b\u011bny na z\u00e1klad\u011b dobrovoln\u00fdch licenc\u00ed od Gileadu (Sovaldi, Harvoni, Epclusa), AbbVie a BMS. Jsou bioekvivalentn\u00ed a obsahuj\u00ed stejnou molekulu. Mnoho studi\u00ed z re\u00e1ln\u00e9 praxe (CT2, Plus-Asia) ukazuje stejn\u00e9 m\u00edry SVR12 jako u origin\u00e1ln\u00edch produkt\u016f.<\/p>\n<h3>L\u00e9kov\u00e9 interakce, na kter\u00e9 si d\u00e1t pozor?<\/h3>\n<p>Nejd\u016fle\u017eit\u011bj\u0161\u00ed: amiodaron + sofosbuvir (\u010dern\u00e1 v\u00fdstraha pro bradykardii), rifampicin (sni\u017euje hladiny DAA), PPI (sni\u017euj\u00ed \u00fa\u010dinek ledipasviru\/velpatasviru), u koinfekce HIV jsou nutn\u00e9 \u00fapravy ARV. V\u017edy sd\u011blte v\u0161echny l\u00e9ky v\u010detn\u011b bylinn\u00fdch\/voln\u011b prodejn\u00fdch.<\/p>\n<h3>Po vyl\u00e9\u010den\u00ed \u2014 mohu se znovu nakazit HCV?<\/h3>\n<p>Ano. SVR odstran\u00ed sou\u010dasnou infekci, ale neposkytuje budouc\u00ed imunitu. Reinfekce novou expozic\u00ed (IV u\u017e\u00edv\u00e1n\u00ed drog, nebezpe\u010dn\u00e9 l\u00e9ka\u0159sk\u00e9 z\u00e1kroky, MSM s koinfekc\u00ed HIV) je mo\u017en\u00e1. Poskytn\u011bte poradenstv\u00ed o prevenci a nab\u00eddn\u011bte testov\u00e1n\u00ed HCV RNA p\u0159i jak\u00e9koli nov\u00e9 rizikov\u00e9 expozici.<\/p>\n<p class=\"medsbase-link-boost-2026-04-30\" data-marker=\"mb-link-boost-hepcinat-lp\">Hepcvir-L a <a href='\/cs\/hepcinat-lp\/'>Hepcinat LP<\/a> jsou klinicky zam\u011bniteln\u00e9 fixn\u00ed kombinace sofosbuviru + ledipasviru \u2014 oba jsou WHO-GMP-certifikovan\u00e9 indick\u00e9 generick\u00e9 verze Harvoni, se stejnou \u00fa\u010dinnost\u00ed, stejn\u00fdmi d\u00e1vkami a stejn\u00fdmi SVR12 sazbami.<\/p>\n<p data-mb-link-target=\"hepcinat-lp\" style=\"margin-top:1em;font-size:0.95em;color:#444;border-left:3px solid #2c7cb0;padding:0.5em 0.75em;background:#f4f8fb;\"><strong>Viz tak\u00e9:<\/strong> <a href=\"https:\/\/medsbase.com\/cs\/hepcinat-lp\/\"><strong>Hepcinat LP<\/strong><\/a> \u2014 Generick\u00fd Harvoni od Natco \u2014 sofosbuvir 400 mg + ledipasvir 90 mg v jednom 12t\u00fddenn\u00edm kurzu pro hepatitidu C genotypy 1, 4, 5, 6.<\/p>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h2>Dal\u0161\u00ed l\u00e9ky na hepatitidu C<\/h2>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/cs\/velpanat\/\">Velpanat<\/a> \u2014 sofosbuvir + velpatasvir \u2014 pan-genotypick\u00e1 alternativa v\u010detn\u011b G2 a G3<\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/hepcvel\/\">Hepcvel<\/a> \u2014 sofosbuvir + velpatasvir \u2014 zna\u010dka Cipla<\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/natdac\/\">Natdac<\/a> \u2014 daclatasvir 30\/60 mg \u2014 alternativn\u00ed inhibitor NS5A pro partnera sofosbuvir<\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/myhep\/\">MyHep<\/a> \u2014 monoterapie sofosbuvirem 400 mg jako z\u00e1kladn\u00ed l\u00e9\u010dba<\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/hepcvir\/\">Hepcvir<\/a> \u2014 sofosbuvir 400 mg \u2014 zna\u010dka Cipla<\/li>\n<\/ul>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:12px 16px;margin:18px 0;border-radius:3px;font-size:.95em;\"><strong>Zdravotn\u00ed upozorn\u011bn\u00ed:<\/strong> Tato str\u00e1nka slou\u017e\u00ed pouze pro informaci a nenahrazuje l\u00e9ka\u0159skou p\u00e9\u010di kvalifikovan\u00e9ho odborn\u00edka. Proberte jak\u00e9koli nov\u00e9 l\u00e9ky se sv\u00fdm l\u00e9ka\u0159em nebo l\u00e9k\u00e1rn\u00edkem.<\/div>","protected":false},"excerpt":{"rendered":"<p>Hepcvir L (Sofosbuvir + Ledipasvir 400 + 90 mg) \u2014 zna\u010dka Cipla pro jednoduch\u00fd re\u017eim HCV genotypu 1\/4\/5\/6 v jedn\u00e9 tablet\u011b. Jednou denn\u011b s j\u00eddlem.<\/p>","protected":false},"featured_media":52287,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3141,3223,3334],"product_tag":[],"class_list":{"0":"post-52286","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-category-overview","7":"product_cat-chronic-conditions","8":"product_cat-hepatitis-medication","10":"first","11":"outofstock","12":"shipping-taxable","13":"purchasable","14":"product-type-variable","15":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product\/52286","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/comments?post=52286"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/media\/52287"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/media?parent=52286"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_brand?post=52286"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_cat?post=52286"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_tag?post=52286"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}